Galderma vs L'Oréal

Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older

Galderma's latest press release announces new three-year data for Nemluvio® in atopic dermatitis, presented at Fall Clinical 2026.

EADV 2026: Galderma’s new data show sustained improvements with Nemluvio® (nemolizumab) for up to three years in patients with moderate-to-severe atopic dermatitis

Galderma announced new three-year data from the ARCADIA long-term extension study showing that Nemluvio (nemolizumab) provides sustained improvements in moderate-to-severe atopic dermatitis for up to 152 weeks. At Week 152, up to 91% of patients achieved EASI-75, up to 67% achieved near-complete skin clearance, and approximately 90% reported clinically meaningful improvements in itch and quality of life. The findings were presented at the EADV 2026 Congress in Vienna, Austria, which runs September 30 to October 3, 2026. Nemluvio is approved for both moderate-to-severe atopic dermatitis and prurigo nodularis in more than 40 countries.

• Galderma published the press release on September 30, 2026, announcing new three-year ARCADIA long-term extension data for Nemluvio (nemolizumab) in moderate-to-severe atopic dermatitis.
• At Week 152, up to 91% of patients achieved EASI-75, up to 75% achieved EASI-90, up to 67% achieved IGA 0/1, up to 88% achieved clinically meaningful itch relief, and up to 92% achieved clinically meaningful quality-of-life improvement.
• The findings were presented at the EADV 2026 Congress in Vienna, Austria, with the oral presentation scheduled for Thursday, October 1, 2026.

Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies

Galderma has been added to the Swiss Market Index (SMI), marking its inclusion among Switzerland's leading blue-chip companies. This is a major corporate milestone for the company.

L'Oréal Q3 Sales Double-Digit Growth, Luxury & Skincare Strong

L'Oréal reported a 7.7% increase in nine-month sales to €35.34 billion, with comparable growth of 6.9%. Third-quarter sales rose 11.9% reported (7.2% comparable) to €11.56 billion, accelerated by strong demand for hair care, perfumes, and skincare. E-commerce grew about 17%, particularly in emerging markets like India and Southeast Asia. Professional Products led with 16.1% growth, while Dermatological Beauty rose 11.2%. The Luxe division grew 7%, with perfumes from YSL, Prada, and Armani performing well. Europe grew 9.6%, and emerging markets in South Asia, Pacific, Middle East, and Sub-Saharan Africa grew 15.7%. L'Oréal completed a majority acquisition of Indian personal care firm Innovist, partnered with Nykaa for beauty brand investments, and with South Korean Cosmax for beauty tech development. The company also issued €2 billion in bonds for corporate purposes. CEO Nicolas Hieronimus expects continued growth for the full year.

• L'Oréal reported nine-month sales of €35.34 billion, up 7.7% reported and 6.9% like-for-like.
• Q3 sales reached €11.56 billion, up 11.9% reported and 7.2% like-for-like.
• E-commerce sales grew around 17%, with strong performance in emerging markets.

Search 2.0: How Brands Stay Visible in AI Era

The article discusses the impact of AI on brand visibility and search, focusing on the 'Search 2.0' trend. As AI-powered chatbots like ChatGPT, Claude, and Perplexity gain popularity, users increasingly rely on AI-generated summaries, leading to a 'zero-click' behavior where they don't click through to websites. This shift is affecting brands and media, which must adapt to remain visible. The article highlights a panel at the HORIZONT Digital Marketing Days featuring experts from L'Oréal, PIA Media, and Reddit. It also mentions predictions that conversational ads in AI applications will become the top digital ad channel by 2031, with potential spending of nearly €2.8 billion. L'Oréal's partnership with OpenAI and the role of Generative Engine Optimization (GEO) are discussed as strategies for brands to maintain visibility.

• L'Oréal announced a partnership with OpenAI in June 2026 to develop AI-powered customer journeys and integrate ChatGPT into Maybelline's virtual makeup try-on.
• L'Oréal's brands SkinCeuticals, CeraVe, and Garnier are part of OpenAI's global ChatGPT advertising pilot project.
• The BVDW and Die Mediaagenturen predict conversational ads in AI applications will become the top digital ad channel by 2031.

OpenAI Expands ChatGPT Ads to 89 Countries

OpenAI has expanded its ChatGPT advertising platform to 26 additional countries, bringing the total to 89 markets, with over half in Latin America including Argentina, Chile, and Colombia. Since its launch about eight months ago, more than 100,000 advertisers have run campaigns, though active advertisers are estimated at 60,000 as of early October. ChatGPT has over 1.2 billion weekly users, positioning it as a significant touchpoint during consumer decision-making. Ads are clearly labeled and do not influence AI responses; they appear only in Free and Go tiers, while Plus, Pro, and Enterprise remain ad-free. OpenAI has introduced a new visual ad format with larger images, initially tested in the US, and continues to expand ad formats, campaign objectives, booking options, and measurement capabilities.

• OpenAI expands ChatGPT Ads to 89 countries, including 26 new markets.
• More than 100,000 advertisers have used the platform; active advertisers estimated at 60,000 as of early October.
• ChatGPT has over 1.2 billion weekly users.